RS
Robert Bernard Stockman
Director

Robert Bernard Stockman insider trades: REVA Medical (RVA.AX) stock buys and sales

Director, REVA Medical Last trade Nov 11, 2019 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2007
5
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 11, 2019RVA.AX↑ Buy$112
Jun 29, 2018RVA.AX↑ Buy$50K
Dec 29, 2017RVA.AX↑ Buy$53K
Jul 14, 2016RVA:AX↑ Buy$150K
Mar 29, 2016RVA:AX↑ Buy$55K
Jun 3, 2015RVA:AX↑ Buy$25K
Nov 21, 2014RVA:AX↑ Buy$95K
Dec 10, 2013RVA:AX↑ Buy$52K
Jun 7, 2012HTWR↓ Sell$250K
Aug 24, 2011RVA↑ Buy$157K
Aug 23, 2011HTWR↑ Buy$91K
Jul 26, 2007ASX:HTW↑ Buy$265K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert Bernard Stockman's insider trades

Robert Bernard Stockman is a director at REVA Medical (RVA.AX). Since Jul 26, 2007, Robert has reported 11 open-market purchases worth $993K and 1 sale worth $250K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (13 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVA.AX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.